Susquehanna International Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.95B Sell
3,210,800
-1,167,200
-27% -$1.18B 0.33% 46
2025
Q4
$4.7B Sell
4,378,000
-489,900
-10% -$468M 0.54% 29
2025
Q3
$3.71B Buy
4,867,900
+1,475,900
+44% +$1.1B 0.42% 42
2025
Q2
$2.64B Buy
3,392,000
+854,200
+34% +$664M 0.37% 41
2025
Q1
$2.1B Buy
2,537,800
+171,600
+7% +$143M 0.36% 43
2024
Q4
$1.83B Buy
2,366,200
+203,000
+9% +$168M 0.28% 52
2024
Q3
$1.92B Buy
2,163,200
+99,100
+5% +$89.1M 0.33% 40
2024
Q2
$1.87B Sell
2,064,100
-217,000
-10% -$174M 0.35% 43
2024
Q1
$1.77B Buy
2,281,100
+414,200
+22% +$295M 0.31% 49
2023
Q4
$1.09B Sell
1,866,900
-42,700
-2% -$24.9M 0.21% 65
2023
Q3
$1.03B Buy
1,909,600
+343,900
+22% +$177M 0.21% 57
2023
Q2
$734M Sell
1,565,700
-634,600
-29% -$266M 0.15% 83
2023
Q1
$756M Buy
2,200,300
+64,400
+3% +$21.7M 0.16% 84
2022
Q4
$781M Buy
2,135,900
+59,500
+3% +$21.1M 0.2% 76
2022
Q3
$671M Buy
2,076,400
+783,800
+61% +$248M 0.17% 69
2022
Q2
$419M Sell
1,292,600
-8,400
-0.6% -$2.52M 0.1% 142
2022
Q1
$373M Sell
1,301,000
-134,700
-9% -$34.7M 0.06% 221
2021
Q4
$397M Buy
1,435,700
+210,300
+17% +$53.3M 0.06% 266
2021
Q3
$283M Sell
1,225,400
-759,400
-38% -$187M 0.04% 394
2021
Q2
$456M Buy
1,984,800
+706,500
+55% +$142M 0.06% 245
2021
Q1
$239M Buy
1,278,300
+150,900
+13% +$29.5M 0.04% 390
2020
Q4
$190M Buy
1,127,400
+113,600
+11% +$17M 0.03% 434
2020
Q3
$150M Sell
1,013,800
-119,900
-11% -$18.6M 0.03% 424
2020
Q2
$186M Buy
1,133,700
+26,900
+2% +$4.13M 0.04% 317
2020
Q1
$154M Buy
1,106,800
+135,500
+14% +$18.6M 0.05% 276
2019
Q4
$128M Buy
971,300
+138,300
+17% +$16M 0.04% 398
2019
Q3
$93.2M Sell
833,000
-282,800
-25% -$31.5M 0.03% 462
2019
Q2
$124M Sell
1,115,800
-1,444,400
-56% -$170M 0.04% 349
2019
Q1
$332M Buy
2,560,200
+858,200
+50% +$104M 0.14% 115
2018
Q4
$197M Sell
1,702,000
-68,700
-4% -$7.67M 0.08% 217
2018
Q3
$190M Buy
1,770,700
+824,800
+87% +$82.5M 0.06% 266
2018
Q2
$80.7M Sell
945,900
-100,700
-10% -$8.27M 0.03% 477
2018
Q1
$81M Sell
1,046,600
-2,326,300
-69% -$187M 0.03% 462
2017
Q4
$285M Buy
3,372,900
+1,799,300
+114% +$153M 0.1% 168
2017
Q3
$135M Sell
1,573,600
-280,900
-15% -$23M 0.05% 296
2017
Q2
$153M Sell
1,854,500
-704,200
-28% -$57.5M 0.07% 240
2017
Q1
$215M Sell
2,558,700
-718,000
-22% -$57.5M 0.11% 159
2016
Q4
$241M Buy
3,276,700
+869,600
+36% +$64.8M 0.12% 138
2016
Q3
$193M Buy
2,407,100
+292,200
+14% +$23.4M 0.09% 169
2016
Q2
$167M Buy
2,114,900
+415,000
+24% +$31.2M 0.09% 194
2016
Q1
$122M Sell
1,699,900
-230,700
-12% -$17.5M 0.07% 257
2015
Q4
$163M Sell
1,930,600
-458,800
-19% -$38.1M 0.08% 220
2015
Q3
$200M Sell
2,389,400
-58,900
-2% -$4.97M 0.09% 199
2015
Q2
$204M Buy
2,448,300
+516,000
+27% +$39.3M 0.09% 191
2015
Q1
$140M Sell
1,932,300
-128,000
-6% -$9.11M 0.06% 271
2014
Q4
$142M Buy
2,060,300
+549,600
+36% +$37.1M 0.06% 303
2014
Q3
$98M Sell
1,510,700
-307,700
-17% -$19.5M 0.04% 416
2014
Q2
$113M Sell
1,818,400
-776,700
-30% -$46.3M 0.05% 332
2014
Q1
$153M Buy
2,595,100
+817,700
+46% +$45.6M 0.07% 237
2013
Q4
$90.6M Sell
1,777,400
-214,600
-11% -$10.7M 0.04% 386
2013
Q3
$100M Buy
1,992,000
+397,600
+25% +$20.8M 0.05% 309
2013
Q2
$78.3M Buy
+1,594,400
New +$86.8M 0.04% 354

Other funds holding LLY

Susquehanna International Group's LLY Position: Q1 2026 in Review

Susquehanna International Group reduced its Eli Lilly (LLY) stake by 35% in Q1 2026, selling an estimated $42.1M and leaving 78,552 shares worth $72.2M. The position accounts for 0.01% of the portfolio, ranked #1025.

Susquehanna International Group first reported a position in LLY in Q2 2013 and has held it in 48 quarters since. The position peaked at $383M in Q3 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Susquehanna International Group held 78,552 shares of Eli Lilly worth $72.2M as of Q1 2026.
  • Susquehanna International Group sold 41,523 Eli Lilly shares in Q1 2026, an estimated $42.1M.
  • Eli Lilly made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1025 holding.
  • Susquehanna International Group first reported a position in Eli Lilly in Q2 2013 and has held it in 48 quarters since.
  • Susquehanna International Group's Eli Lilly position peaked at $383M in Q3 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.